Trial site
Smilow Cancer Hospital at Yale - New Haven
- 17running trials
- 9closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer5 trials
- Endometrial cancer4 trials
- Metastatic breast cancer4 trials
- Lung cancer3 trials
- Myelodysplastic syndromes2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Brain metastases1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- and 11 more
- Phase
- Phase 210 trials
- Phase 310 trials
- Phase 1/24 trials
- Phase 12 trials
- Status
- Active, not recruiting9 trials
- Completed8 trials
- Recruiting8 trials
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche4 trials
- Yale University4 trials
- Pfizer3 trials
- Daiichi Sankyo2 trials
- Agios Pharmaceuticals, Inc.1 trial
- and 12 more
Running trials
Recruiting
Recruiting
Active, not recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Recruiting
Recruiting
Active, not recruiting
A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Recruiting
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Cervical cancer1 recruiting
- Endometrial cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Completed
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Completed
Completed
Completed
Terminated
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026